Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yui Tomo

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Neuropsychopharmacology Reports|January 24, 2022
Ifenprodil for the treatment of methamphetamine use disorder: An exploratory, randomized, double-blind, placebo-controlled trialHiroko Kotajima-Murakami, Ayumi Takano, Shinya Hirakawa, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|February 13, 2026
Pharmacological interventions for social cognitive impairments in schizophrenia: A systematic review and network meta-analysis of randomized controlled trialsYuji Yamada, Norio Watanabe, Yui Tomo, et al.
Frontiers in Psychology|August 22, 2022
Pharmacological interventions for social cognitive impairments in schizophrenia: A protocol for a systematic review and network meta-analysisYuji Yamada, Ryo Okubo, Hisateru Tachimori, et al.
Annals of Nuclear Medicine|October 4, 2022
Clinical impact of amyloid PET using <sup>18</sup>F-florbetapir in patients with cognitive impairment and suspected Alzheimer's disease: a multicenter studyHiroshi Matsuda, Kyoji Okita, Yumiko Motoi, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|July 15, 2025
Transforming Growth Factor-β Serum Levels Associated with Social Function in Subjects at Ultra-high Risk for Psychosis: A Multicenter StudyYuji Yamada, Naoko Kishimoto, Hiromi Tagata, et al.
Annals of Clinical and Translational Neurology|October 26, 2023
Natural history of Becker muscular dystrophy: a multicenter study of 225 patientsAkinori Nakamura, Tsuyoshi Matsumura, Katsuhisa Ogata, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Neuropsychopharmacology Reports|January 24, 2022
Ifenprodil for the treatment of methamphetamine use disorder: An exploratory, randomized, double-blind, placebo-controlled trialHiroko Kotajima-Murakami, Ayumi Takano, Shinya Hirakawa, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|February 13, 2026
Pharmacological interventions for social cognitive impairments in schizophrenia: A systematic review and network meta-analysis of randomized controlled trialsYuji Yamada, Norio Watanabe, Yui Tomo, et al.
Frontiers in Psychology|August 22, 2022
Pharmacological interventions for social cognitive impairments in schizophrenia: A protocol for a systematic review and network meta-analysisYuji Yamada, Ryo Okubo, Hisateru Tachimori, et al.
Annals of Nuclear Medicine|October 4, 2022
Clinical impact of amyloid PET using <sup>18</sup>F-florbetapir in patients with cognitive impairment and suspected Alzheimer's disease: a multicenter studyHiroshi Matsuda, Kyoji Okita, Yumiko Motoi, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|July 15, 2025
Transforming Growth Factor-β Serum Levels Associated with Social Function in Subjects at Ultra-high Risk for Psychosis: A Multicenter StudyYuji Yamada, Naoko Kishimoto, Hiromi Tagata, et al.
Annals of Clinical and Translational Neurology|October 26, 2023
Natural history of Becker muscular dystrophy: a multicenter study of 225 patientsAkinori Nakamura, Tsuyoshi Matsumura, Katsuhisa Ogata, et al.
Pageof 2